These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28586014)

  • 21. Enhancement of the adhesive and spreading potentials of ovarian carcinoma RMG-1 cells due to increased expression of integrin alpha5beta1 with the Lewis Y-structure on transfection of the alpha1,2-fucosyltransferase gene.
    Yan LM; Lin B; Zhu LC; Hao YY; Qi Y; Wang CZ; Gao S; Liu SC; Zhang SL; Iwamori M
    Biochimie; 2010 Jul; 92(7):852-7. PubMed ID: 20172014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.
    Gao S; Zhu L; Feng H; Hu Z; Jin S; Song Z; Liu D; Liu J; Hao Y; Li X; Lin B
    Tumour Biol; 2016 Sep; 37(9):12251-12262. PubMed ID: 27240592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
    Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
    J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.
    Yan L; Wang C; Lin B; Liu J; Liu D; Hou R; Wang Y; Gao L; Zhang S; Iwamori M
    Biochimie; 2015 Jun; 113():17-25. PubMed ID: 25726913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of EMMPRIN expression in ovarian epithelial carcinomas.
    Zhao Y; Chen S; Gou WF; Niu ZF; Zhao S; Xiao LJ; Takano Y; Zheng HC
    Cell Cycle; 2013 Sep; 12(17):2899-913. PubMed ID: 23966157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer.
    Bao X; Zhao S; Liu T; Liu Y; Liu Y; Yang X
    J Histochem Cytochem; 2013 Mar; 61(3):206-17. PubMed ID: 23292799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
    Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
    Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
    Wang ZQ; Bachvarova M; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Bachvarov D
    Oncotarget; 2014 Jan; 5(2):544-60. PubMed ID: 24504219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancers.
    Lee YK; Park NH; Lee H
    Exp Mol Med; 2015 Nov; 47(11):e195. PubMed ID: 26584681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase.
    Yan Q; Wang F; Miao Y; Wu X; Bai M; Xi X; Feng Y
    Tumour Biol; 2016 Sep; 37(9):12263-12271. PubMed ID: 27251670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.
    Zhang F; Liu J; Lin B; Liu Q; Zhao Y; Zhu L; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(11):7323-34. PubMed ID: 22174601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway.
    Liu JJ; Lin B; Hao YY; Li FF; Liu DW; Qi Y; Zhu LC; Zhang SL; Iwamori M
    Oncol Rep; 2010 Mar; 23(3):833-41. PubMed ID: 20127027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dub3 expression correlates with tumor progression and poor prognosis in human epithelial ovarian cancer.
    Zhou B; Shu B; Xi T; Su N; Liu J
    Biomed Pharmacother; 2015 Mar; 70():84-9. PubMed ID: 25776484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion.
    Wang S; Wei H; Zhang S
    BMC Cancer; 2017 Jun; 17(1):455. PubMed ID: 28666421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and isolation of MUC1 mucin from larynx squamous cell carcinoma.
    Croce MV; Price MR; Segal-Eiras A
    Pathol Oncol Res; 2000; 6(2):93-9. PubMed ID: 10936782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the upregulation of Topo-I and Topo-II β.
    Wang C; Yan L; Wang Y; Lin B; Liu S; Li Q; Gao L; Zhang S; Iwamori M
    Anat Rec (Hoboken); 2011 Jun; 294(6):961-9. PubMed ID: 21542140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.